Clinical Trials Arena on MSN

Parkinson’s stem cell therapy demonstrates promise in Phase II trial

This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...
Business Wire

First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today announced dosing ...
Cure Today

Phase 2 Trial of Firi-Cel CAR T-Cell Therapy Discontinued in Lymphoma

The FIRCE-1 trial for firi-cel in LBCL patients was discontinued due to insufficient therapeutic advantage and safety concerns. Firi-cel showed a 77% overall response rate, but only 18% of complete ...
Nasdaq

BriaCell’s Phase 3 Study Progresses in Cancer Fight

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter BriaCell Therapeutics has received ...
News-Medical.Net on MSN

Nascent polypeptide-associated complex regulates early stages of protein formation

To ensure that protein production in our cells runs smoothly, the protein complex NAC slows down the rate of protein ...